NCT06093568View on ClinicalTrials.gov

Delving Into Participation Trends in Renal Cell Carcinoma Studies

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2026

Conditions
Renal Cell Carcinoma
Trial Locations (1)

94107

Power Life Sciences, San Francisco

Sponsors
All Listed Sponsors
lead

Power Life Sciences Inc.

INDUSTRY

NCT06093568 - Delving Into Participation Trends in Renal Cell Carcinoma Studies | Biotech Hunter | Biotech Hunter